Advanced search
Publication Cover
Ocular Immunology and Inflammation Volume 27, 2019 - Issue 4
Submit an article Journal homepage
297
Views
8
CrossRef citations to date
0
Altmetric
Original Articles

Relapse of Juvenile Idiopathic Arthritis-Associated Uveitis after Discontinuation of Immunomodulatory Therapy

Nisha R. AcharyaF.I. Proctor Foundation, University of California San Francisco, San Francisco, California, USA;Department of Ophthalmology, University of California San Francisco, San Francisco, California, USA;Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, California, USACorrespondence[email protected]
View further author information
,
Sarju PatelDepartment of Ophthalmology, University of Illinois at Chicago, Chicago, Illinois, USA;Retina Consultants Medical Group, Inc, Sacramento, CA, USAView further author information
,
Gelareh HomayounfarF.I. Proctor Foundation, University of California San Francisco, San Francisco, California, USAView further author information
,
Wayne T. A. EnanoriaF.I. Proctor Foundation, University of California San Francisco, San Francisco, California, USAView further author information
,
Akbar ShakoorF.I. Proctor Foundation, University of California San Francisco, San Francisco, California, USA;Moran Eye Center, University of Utah, Salt Lake City, Utah, USAView further author information
,
Anindita ChakrabartiDepartment of Ophthalmology, University of Illinois at Chicago, Chicago, Illinois, USAView further author information
&
Debra A. GoldsteinDepartment of Ophthalmology, University of Illinois at Chicago, Chicago, Illinois, USA;Department of Ophthalmology, Northwestern University, Evanston, Illinois, USAView further author information
 show all
Pages 686-692 | Received 30 Jul 2017, Accepted 02 Jan 2018, Published online: 16 Feb 2018

References

  • Petty RE, Southwood TR, Manners P, et al. International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001. J Rheumatol. 2004;31(2):390–392.
  • Gregory AC, Kempen JH, Daniel E, et al. Risk factors for loss of visual acuity among patients with uveitis associated with juvenile idiopathic arthritis: the Systemic Immunosuppressive Therapy for Eye Diseases Study. Ophthalmology. 2013;120(1):186–192.
  • Thorne JE, Woreta F, Kedhar SR, et al. Juvenile idiopathic arthritis-associated uveitis: incidence of ocular complications and visual acuity loss. Am J Ophthalmol. 2007;143(5):840–846.
  • Jabs DA, Rosenbaum JT. Guidelines for the use of immunosuppressive drugs in patients with ocular inflammatory disorders: recommendations of an expert panel. Am J Ophthalmol. 2001;131(5):679.
  • Simonini G, Cantarini L, Bresci C, et al. Current therapeutic approaches to autoimmune chronic uveitis in children. Autoimmun Rev. 2010;9(10):674–683.
  • Rifkin LM, Birnbaum AD, Goldstein DA. TNF Inhibition for Ophthalmic Indications: current Status and Outlook. BioDrugs. 2013;27(4):347–357.
  • Martel JN, Esterberg E, Nagpal A, et al. Infliximab and adalimumab for uveitis. Ocul Immunol Inflamm. 2012;20(1):18–26.
  • Ayuso VK, Van De Winkel EL, Rothova A, et al. Relapse rate of uveitis post-methotrexate treatment in juvenile idiopathic arthritis. Am J Ophthalmol. 2011;151(2):217–222.
  • FDA. Tumor Necrosis Factor (TNF) blockers, Azathioprine and/or Mercaptopurine: update on Reports of Hepatosplenic T-Cell Lymphoma in Adolescents and Young Adults. 2011; Available at http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm251443.htm. Accessed November 30, 2013.
  • FDA. Cancer Warnings Required for TNF-Alpha Inhibitors. 2009; Available at http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm175803.htm. Accessed November 30, 2013.
  • Shakoor A, Esterberg E, Acharya NR. Recurrence of Uveitis after Discontinuation of Infliximab. Ocul Immunol Inflamm. September 22, 2013. doi:10.3109/09273948.2013.812222.
  • Yamada Y, Sugita S, Tanaka H, et al. Timing of recurrent uveitis in patients with Behcet’s disease receiving infliximab treatment. Br J Ophthalmol. 2011;95(2):205–208.
  • Adan A, Hernandez V, Ortiz S, et al. Effects of infliximab in the treatment of refractory posterior uveitis of Behcet’s disease after withdrawal of infusions. Int Ophthalmol. 2010;30(5):577–581.
  • Baszis K, Garbutt J, Toib D, et al. Clinical outcomes after withdrawal of anti-tumor necrosis factor alpha therapy in patients with juvenile idiopathic arthritis: a twelve-year experience. Arthritis Rheum. 2011;63(10):3163–3168.
  • Tanaka Y, Takeuchi T, Mimori T, et al. Discontinuation of infliximab after attaining low disease activity in patients with rheumatoid arthritis: RRR (remission induction by Remicade in RA) study. Ann Rheum Dis. 2010;69(7):1286–1291.
  • Bongartz T, Aj S, Mj S, et al. Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: systematic review and meta-analysis of rare harmful effects in randomized controlled trials. Jama. 2006;295(19):2275–2285.
  • Kempen JH, Gangaputra S, Daniel E, et al. Long-term risk of malignancy among patients treated with immunosuppressive agents for ocular inflammation: a critical assessment of the evidence. Am J Ophthalmol. 2008;146(6):802–812.
  • Kempen JH, Daniel E, Dunn JP, et al. Overall and cancer related mortality among patients with ocular inflammation treated with immunosuppressive drugs: retrospective cohort study. Bmj. 2009;339:b2480.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.